- Home
- CRVO vs PAVM Comparison
CRVO vs PAVM Comparison
Compare CRVO & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVO | PAVM |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | United States |
| Employees | N/A | 41 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9M | 41.8M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRVO | PAVM |
|---|---|---|
| Price | $2.29 | $4.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $23.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 61.4K | 9.9K |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,006,510.00 | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.79 | $0.21 |
| 52 Week High | $13.13 | $28.44 |
Technical Indicators
Market Signals| Indicator | CRVO | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 23.02 | 27.51 |
| Support Level | N/A | $0.34 |
| Resistance Level | $4.27 | $6.63 |
| Average True Range (ATR) | 0.21 | 0.45 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 8.03 | 22.54 |
Price Performance
Historical ComparisonAbout CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.